Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells
{{output}}
Chimeric antigen receptor (CAR) T cell therapy targeting CD19 elicits remarkable clinical efficacy in B cell malignancies, but many patients relapse owing to failed expansion and/or progressive loss of CAR-T cells. We recently reported a strategy to potently r... ...
